This training will cover compliance requirements for running clinical trials in pediatrics, particularly in the EU to comply with the EU ethical considerations guidance for running clinical trials in pediatrics.
This webinar will provide critical assistance to FDA and EMA regulated companies currently carrying out or preparing to conduct clinical trials for pharmaceutical, biotechnology, and biologics products in paediatrics.
Laura BrownIndependent QA and Training Consultant, Laura Brown Training and Development
Dr Laura Brown is an independent Pharmaceutical QA, Management and Training Consultant, and Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. Laura has more than 20 years' experience of Quality Assurance and managing international clinical trials including risk identification and management and risk based monitoring. She has worked for several companies including GSK, Hoechst Marion Roussel, Good Clinical Research Practices and Phoenix International. She has consulted with numerous pharmaceutical companies, suppliers to the pharmaceutical industry as well as academic institutions.
Dr Brown has an MBA with specialization in project management including risk management. She is also the external project management expert for a pharmaceutical e-learning MSc module in project management covering risk management, and the author of two books on project management including the leading book “Pharmaceutical Project Management” (Gower).
Serious medication errors due to the off-label and unlicensed use of medicines in the pediatric population have led the EMA and the FDA to develop the regulations for testing medicines in the pediatric population. The Pediatric Regulation in the EU mandate pharmaceutical companies test medicines on children. It is essential that children have safe, effective medicines but this needs to be balanced against the money companies will make. Pharmaceutical companies therefore need scrupulous ethical safeguards to ensure fully informed consent from parents and assent from the children. This will facilitate children's research needs and refute accusations of using children for profit.
Children are not small adults and have different needs and expectations when it comes to making sure their medicines are safe and effective. This has a huge impact concerning the ethics of using children in pharmaceutical studies as they have limited understanding and may not be able to make informed decisions. There is therefore a huge weight of ethical responsibility on the pharmaceutical researcher to take particular care when running such studies.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. FDATrainingAlert would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.
Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.
If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.
We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@fdatrainingalert.com call +1-888-771-6965 (Toll Free).
This product hasn't received any reviews yet. Be the first to review this product! Write review
